Skip to main content

Table 3 Time to cure of MSC group versus non-MSC group

From: Mesenchymal stromal cell treatment improves outcomes in children with pneumonia post-hematopoietic stem cell transplantation: a retrospective cohort study

  Median days (95% CI) Odd ratio (95% CI) p value
Severe pneumonia
 MSC group (n = 16) 36 (19–52) 0.32 (0.12–0.88) 0.009
 Non-MSC group (n = 15) 62 (42–81) Ref  
Non-severe pneumonia
 MSC group (n = 31) 28 (24–31) 0.31 (0.18–0.56) 0.003
 Non-MSC group (n = 45) 33 (26–39) Ref  
All cases
 MSC group (n = 47) 29 (25–34) 0.46 (0.29–0.73) 0.003
 Non-MSC group (n = 60) 44 (38–52) Ref